Annaida Technologies

How to finance laboratory equipment?
Save capital for milestones?

Made possible by Würth Leasing.

The Company

Magnetic resonance spectroscopy typically requires large, room-filling devices. Annaida Technologies has integrated it onto a microchip. This makes it possible to measure the metabolic chemistry of individual cells and embryos without damaging the sample. There are two main areas of application: reproductive medicine, where embryos will in the future be evaluated without invasive procedures, and life sciences research.

An EPFL spin-off based in the Lausanne Innovation Park, with nine employees. On the advisory board: Kurt Wüthrich, Nobel Prize laureate in Chemistry for NMR spectroscopy. The core patent has been granted in the EU, Japan, China, the U.S., and Israel. In April 2025, Annaida completed a Pre-Series A funding round, followed in June 2026 by certification under ISO 13485, the standard for medical devices.

Anyone conducting measurements on a micro scale needs reference values from a top-of-the-line instrument. That is why the first major laboratory purchase was scheduled for 2025: a 400-MHz NMR spectrometer.

The Starting Point

For a company with nine employees, this isn’t the kind of investment you make on the side. Annaida is funded through financing rounds, not through ongoing cash flow. Every franc spent on hardware is money that’s not going toward development—and thus toward the very milestones against which the next funding round will be judged. A direct purchase would have tied up a significant portion of the available funds all at once. There was no time pressure—no delivery date, no deadline. The pressure lay elsewhere: in the question of how long the available capital would last.

The central question

How can a state-of-the-art device be brought into the lab without tying up the funds needed for research and the next milestones?

The Solution from Würth Leasing

Würth Leasing financed the spectrometer with a loan of CHF 250,000 over a 48-month term.

The offer was preceded by a thorough review. A company with nine employees, whose liquidity comes from financing rounds, does not fit into any standard framework. Würth Leasing assessed the case on a case-by-case basis and then submitted an offer tailored to the actual situation.

Three points were crucial to the solution:

The result

The spectrometer became operational without diverting funds from ongoing development. Annaida met the project goals on schedule and made faster progress toward the technical milestones than would have been possible with limited liquidity.

Liquidity	CHF 250,000 is not tied up all at once, but spread out over 48 months
Pace of development	Project Goals Achieved on Schedule
Financing	Milestones achieved unlocked additional funding
Features	400-MHz NMR spectrometer in our own laboratory
Predictability	Fixed payments over 84 months

The Collaboration

Only a few months passed between the initial meeting and the finalization of the financing. Annaida turned to Würth Leasing again for additional investment projects.

Are you facing a similar situation?

Whether it’s your first major laboratory purchase, an upgrade to your equipment, or growth during a capital-intensive phase: Our leasing specialists will work with you to develop a customized solution—personally, independently, and as equals.